These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 32002785)

  • 1. Neurovascular unit dysregulation, white matter disease, and executive dysfunction: the shared triad of vascular cognitive impairment and Alzheimer disease.
    Levit A; Hachinski V; Whitehead SN
    Geroscience; 2020 Apr; 42(2):445-465. PubMed ID: 32002785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association.
    Gorelick PB; Scuteri A; Black SE; Decarli C; Greenberg SM; Iadecola C; Launer LJ; Laurent S; Lopez OL; Nyenhuis D; Petersen RC; Schneider JA; Tzourio C; Arnett DK; Bennett DA; Chui HC; Higashida RT; Lindquist R; Nilsson PM; Roman GC; Sellke FW; Seshadri S;
    Stroke; 2011 Sep; 42(9):2672-713. PubMed ID: 21778438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular Cognitive Impairment (VCI).
    Rundek T; Tolea M; Ariko T; Fagerli EA; Camargo CJ
    Neurotherapeutics; 2022 Jan; 19(1):68-88. PubMed ID: 34939171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Executive dysfunction in vascular cognitive impairment in the consortium to investigate vascular impairment of cognition study.
    Moorhouse P; Song X; Rockwood K; Black S; Kertesz A; Gauthier S; Feldman H;
    J Neurol Sci; 2010 Jan; 288(1-2):142-6. PubMed ID: 19840883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological assessment and cerebral vascular disease: the new standards.
    Godefroy O; ; Leclercq C; Bugnicourt JM; Roussel M; Moroni C; Quaglino V; Beaunieux H; Taillia H; Nédélec-Ciceri C; Bonnin C; Thomas-Anterion C; Varvat J; Aboulafia-Brakha T; Assal F
    Rev Neurol (Paris); 2013 Oct; 169(10):779-85. PubMed ID: 23999023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinergic circuitry functioning in patients with vascular cognitive impairment--no dementia.
    Bella R; Cantone M; Lanza G; Ferri R; Vinciguerra L; Puglisi V; Pennisi M; Ricceri R; Di Lazzaro V; Pennisi G
    Brain Stimul; 2016; 9(2):225-33. PubMed ID: 26515786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive Dysfunction in White Matter Disorders: New Perspectives in Treatment and Recovery.
    Filley CM
    J Neuropsychiatry Clin Neurosci; 2021; 33(4):349-355. PubMed ID: 34340526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astroglial NF-kB contributes to white matter damage and cognitive impairment in a mouse model of vascular dementia.
    Saggu R; Schumacher T; Gerich F; Rakers C; Tai K; Delekate A; Petzold GC
    Acta Neuropathol Commun; 2016 Aug; 4(1):76. PubMed ID: 27487766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor involvement in vascular cognitive impairment and vascular dementia pathogenesis and treatment.
    Nguyen DH; Cunningham JT; Sumien N
    Geroscience; 2021 Feb; 43(1):159-166. PubMed ID: 32902819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurovascular-glymphatic dysfunction and white matter lesions.
    Sabayan B; Westendorp RGJ
    Geroscience; 2021 Aug; 43(4):1635-1642. PubMed ID: 33851307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathology and pathophysiology of vascular cognitive impairment. A critical update.
    Jellinger KA
    Panminerva Med; 2004 Dec; 46(4):217-26. PubMed ID: 15876978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherosclerotic risk factors, vascular cognitive impairment, and Alzheimer disease.
    Kovacic JC; Fuster V
    Mt Sinai J Med; 2012; 79(6):664-73. PubMed ID: 23239205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of vascular cognitive impairment and dementia.
    Erkinjuntti T
    J Neural Transm Suppl; 2002; (63):91-109. PubMed ID: 12597611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report.
    Wallin A; Kapaki E; Boban M; Engelborghs S; Hermann DM; Huisa B; Jonsson M; Kramberger MG; Lossi L; Malojcic B; Mehrabian S; Merighi A; Mukaetova-Ladinska EB; Paraskevas GP; Popescu BO; Ravid R; Traykov L; Tsivgoulis G; Weinstein G; Korczyn A; Bjerke M; Rosenberg G
    BMC Neurol; 2017 May; 17(1):102. PubMed ID: 28535786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of White Matter Hyperintensities and Related Risk Factors in Vascular Cognitive Impairment: A Review.
    Chen Y; Wang X; Guan L; Wang Y
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiating between Alzheimer's Disease and Vascular Cognitive Impairment: Is the "Memory Versus Executive Function" Contrast Still Relevant?
    Andriuta D; Roussel M; Barbay M; Despretz-Wannepain S; Godefroy O;
    J Alzheimers Dis; 2018; 63(2):625-633. PubMed ID: 29689726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retained executive abilities in mild cognitive impairment are associated with increased white matter network connectivity.
    Farrar DC; Mian AZ; Budson AE; Moss MB; Koo BB; Killiany RJ;
    Eur Radiol; 2018 Jan; 28(1):340-347. PubMed ID: 28695358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter structural network abnormalities underlie executive dysfunction in amyotrophic lateral sclerosis.
    Dimond D; Ishaque A; Chenji S; Mah D; Chen Z; Seres P; Beaulieu C; Kalra S
    Hum Brain Mapp; 2017 Mar; 38(3):1249-1268. PubMed ID: 27796080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microstructural damage of white-matter tracts connecting large-scale networks is related to impaired executive profile in alcohol use disorder.
    Crespi C; Galandra C; Canessa N; Manera M; Poggi P; Basso G
    Neuroimage Clin; 2020; 25():102141. PubMed ID: 31927501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular contributions to cognitive impairment, clinical Alzheimer's disease, and dementia in older persons.
    Kapasi A; Schneider JA
    Biochim Biophys Acta; 2016 May; 1862(5):878-86. PubMed ID: 26769363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.